Abu Dhabi Launches Drug and Poison Information Service to Improve Healthcare Outcomes
Abu Dhabi has launched its Drug and Poison Information Service. The aim is to raise awareness on the safe drugs use and the necessary procedures to prevent poisoning. This will strengthen research efforts in the Emirate to further develop the clinical toxicology field and improve healthcare outcomes. In 2023 the goal is to increase the working hours of the hotline service to become around the clock.
Recent Posts
Tovorafenib Clinical Assessment Outcomes and Methodological Challenges
The Tovorafenib clinical assessment conducted under the EU Joint Clinical Assessment process has exposed critical shortcomings in the evidence base for treating BRAF-altered pediatric low-grade glioma. Despite the therapy’s potential, reviewers concluded that robust comparative data is absent for...
Transformative Impact of Levacetylleucine A-T Treatment in Rare Neurodegenerative Disease
Levacetylleucine A-T treatment has delivered compelling Phase III results, producing statistically significant and clinically meaningful improvements in ataxia severity and daily function for both pediatric and adult patients with ataxia-telangiectasia (A-T). The
Mifepristone Safety Study: Ensuring Continued Regulatory Oversight
The mifepristone safety study launched by the FDA in April 2026 is actively collecting high-quality real-world data to determine whether the current Risk Evaluation and Mitigation Strategy (REMS) program still strikes the right balance between clinical benefits and potential harms.
S...